InsiderTrades.com logo

MAIA Insider Trading

Insider Ownership Percentage: 32.32%
Insider Buying (Last 12 Months): $477,191.59
Insider Selling (Last 12 Months): $0.00

MAIA Biotechnology Insider Trading History Chart

This chart shows the insider buying and selling history at MAIA Biotechnology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MAIA Biotechnology Share Price & Price History

Current Price: $1.98
Price Change: ▲ Price Increase of +0.01 (0.51%)
As of 02/9/2026 05:10 PM ET

This chart shows the closing price history over time for MAIA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

MAIA Biotechnology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2025Ngar Yee LouieDirectorBuy81,699$1.22$99,672.781,248,888View SEC Filing Icon  
12/22/2025Stan SmithDirectorBuy57,189$1.22$69,770.581,421,478View SEC Filing Icon  
12/22/2025Steven M ChaoukiDirectorBuy40,849$1.22$49,835.78151,873View SEC Filing Icon  
12/5/2025Stan SmithDirectorBuy13,740$1.20$16,488.004,580View SEC Filing Icon  
11/28/2025Cristian LuputDirectorBuy18,145$1.11$20,140.95437,628View SEC Filing Icon  
11/28/2025Vlad VitocCEOBuy50,000$1.14$57,000.00881,421View SEC Filing Icon  
11/26/2025Cristian LuputDirectorBuy20,000$1.08$21,600.00419,483View SEC Filing Icon  
11/26/2025Vlad VitocCEOBuy22,000$1.05$23,100.00853,421View SEC Filing Icon  
11/25/2025Cristian LuputDirectorBuy10,000$0.98$9,800.00399,483View SEC Filing Icon  
11/25/2025Stan SmithDirectorBuy15,000$0.98$14,700.001,364,289View SEC Filing Icon  
11/25/2025Vlad VitocCEOBuy10,500$0.97$10,185.00831,421View SEC Filing Icon  
11/24/2025Stan SmithDirectorBuy10,000$0.99$9,900.001,334,289View SEC Filing Icon  
10/1/2025Stan SmithDirectorBuy19,230$1.30$24,999.001,324,289View SEC Filing Icon  
6/3/2025Stan SmithDirectorBuy33,333$1.50$49,999.501,305,059View SEC Filing Icon  
12/13/2024Stan SmithDirectorBuy25,000$1.87$46,750.001,130,060View SEC Filing Icon  
11/1/2024Cristian LuputDirectorBuy22,133$2.51$55,553.83389,483View SEC Filing Icon  
4/25/2024Ngar Yee LouieDirectorBuy19,665$2.03$39,919.951,167,189View SEC Filing Icon  
3/14/2024Stan SmithDirectorBuy170,940$1.17$199,999.80857,568View SEC Filing Icon  
5/18/2023Ramiro GuerreroDirectorBuy1,200$2.47$2,964.00312,672View SEC Filing Icon  
5/15/2023Cristian LuputDirectorBuy3,000$2.63$7,890.00298,068View SEC Filing Icon  
4/28/2023Vlad VitocCEOBuy4,000$2.50$10,000.00809,121View SEC Filing Icon  
4/27/2023Joseph F McguireCFOBuy4,400$2.25$9,900.009,400View SEC Filing Icon  
4/27/2023Ramiro GuerreroDirectorBuy8,500$2.25$19,125.00311,472View SEC Filing Icon  
4/20/2023Stan SmithDirectorBuy10,000$3.74$37,400.00553,328View SEC Filing Icon  
4/17/2023Cristian LuputDirectorBuy1,576$3.69$5,815.44295,068View SEC Filing Icon  
4/13/2023Cristian LuputDirectorBuy622$3.62$2,251.64292,690View SEC Filing Icon  
4/3/2023Vlad VitocCEOBuy1,375$3.50$4,812.50804,196View SEC Filing Icon  
3/30/2023Vlad VitocCEOBuy205$3.43$703.15801,326View SEC Filing Icon  
3/24/2023Stan SmithDirectorBuy938$3.49$3,273.62543,328View SEC Filing Icon  
3/22/2023Stan SmithDirectorBuy1,458$3.18$4,636.44540,528View SEC Filing Icon  
3/20/2023Stan SmithDirectorBuy3,006$3.28$9,859.68536,334View SEC Filing Icon  
3/16/2023Ramiro GuerreroDirectorBuy1,333$3.64$4,852.12301,709View SEC Filing Icon  
3/13/2023Cristian LuputDirectorBuy3,000$4.07$12,210.00292,068View SEC Filing Icon  
3/10/2023Ramiro GuerreroDirectorBuy443$3.98$1,763.14300,376View SEC Filing Icon  
3/8/2023Stan SmithDirectorBuy3,076$4.20$12,919.20529,746View SEC Filing Icon  
3/8/2023Vlad VitocCEOBuy1,581$4.21$6,656.01801,121View SEC Filing Icon  
3/6/2023Stan SmithDirectorBuy4,594$4.39$20,167.66524,709View SEC Filing Icon  
3/6/2023Vlad VitocCEOBuy544$4.24$2,306.56798,101View SEC Filing Icon  
3/3/2023Stan SmithDirectorBuy2,509$4.43$11,114.87520,115View SEC Filing Icon  
3/2/2023Vlad VitocCEOBuy45$4.42$198.90795,159View SEC Filing Icon  
3/1/2023Stan SmithDirectorBuy198$4.48$887.04517,583View SEC Filing Icon  
2/28/2023Vlad VitocCEOBuy1,275$4.49$5,724.75794,832View SEC Filing Icon  
2/27/2023Stan SmithDirectorBuy219$4.47$978.93515,766View SEC Filing Icon  
2/21/2023Stan SmithDirectorBuy228$4.49$1,023.72514,474View SEC Filing Icon  
2/17/2023Vlad VitocCEOBuy73$4.25$310.25793,557View SEC Filing Icon  
2/16/2023Stan SmithDirectorBuy62$4.25$263.50514,171View SEC Filing Icon  
2/15/2023Vlad VitocCEOBuy10$4.25$42.50793,474View SEC Filing Icon  
2/14/2023Stan SmithDirectorBuy198$4.25$841.50514,099View SEC Filing Icon  
2/10/2023Stan SmithDirectorBuy337$4.25$1,432.25513,901View SEC Filing Icon  
2/10/2023Vlad VitocCEOBuy343$4.24$1,454.32793,464View SEC Filing Icon  
9/19/2022Stan SmithDirectorBuy2,700$3.69$9,963.001,424,178View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for MAIA Biotechnology (NYSEAMERICAN:MAIA)

5.65% of MAIA Biotechnology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MAIA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

MAIA Biotechnology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/9/2026Geode Capital Management LLC296,740$0.45M0.0%+9.5%0.801%Search for SEC Filing on Google Icon
2/4/2026Centric Wealth Management586,398$0.90M0.2%+2.0%1.584%Search for SEC Filing on Google Icon
1/23/2026Ritholtz Wealth Management23,071$35K0.0%N/A0.062%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,103,145$1.70M0.0%-3.3%3.344%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC28,783$52K0.0%N/A0.087%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP16,165$29K0.0%N/A0.053%Search for SEC Filing on Google Icon
8/12/2025Centric Wealth Management573,398$1.03M0.2%+740.2%1.892%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC222,183$0.40M0.0%+3.6%0.733%Search for SEC Filing on Google Icon
8/6/2025Centerpoint Advisory Group15,730$28K0.0%N/A0.052%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC39,057$77K0.0%N/A0.149%Search for SEC Filing on Google Icon
2/11/2025Halter Ferguson Financial Inc.240,818$0.48M0.2%-36.1%0.921%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC192,563$0.54M0.0%+22.9%0.760%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd10,991$31K0.0%N/A0.043%Search for SEC Filing on Google Icon
8/8/2024Ground Swell Capital LLC16,460$56K0.0%N/A0.075%Search for SEC Filing on Google Icon
7/9/2024Mather Group LLC.12,060$41K0.0%+50,150.0%0.055%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC32,487$71K0.0%N/A0.149%Search for SEC Filing on Google Icon
10/10/2023FNY Investment Advisers LLC17,550$38K0.0%N/A0.129%Search for SEC Filing on Google Icon
7/20/2023Naviter Wealth LLC22,168$49K0.0%N/A0.163%Search for SEC Filing on Google Icon
2/7/2023Lynwood Capital Management Inc.250,000$0.88M1.1%+25.1%2.283%Search for SEC Filing on Google Icon
1/4/2023Centric Wealth Management40,206$0.14M0.1%N/A0.367%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
MAIA Biotechnology logo
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Read More on MAIA Biotechnology

Today's Range

Now: $1.98
Low: $1.77
High: $1.98

50 Day Range

MA: $1.70
Low: $1.12
High: $2.95

52 Week Range

Now: $1.98
Low: $0.87
High: $3.19

Volume

582,924 shs

Average Volume

1,270,098 shs

Market Capitalization

$73.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of MAIA Biotechnology?

MAIA Biotechnology's top insider investors include:
  1. Stan Smith (Director)
  2. Ngar Yee Louie (Director)
  3. Vlad Vitoc (CEO)
  4. Cristian Luput (Director)
  5. Steven M Chaouki (Director)
Learn More about top insider investors at MAIA Biotechnology.

Who are the major institutional investors of MAIA Biotechnology?

MAIA Biotechnology's top institutional shareholders include:
  1. Centric Wealth Management — 1.58%
  2. Geode Capital Management LLC — 0.80%
  3. Ritholtz Wealth Management — 0.06%
Learn More about top institutional investors of MAIA Biotechnology stock.

Which institutional investors are buying MAIA Biotechnology stock?

Within the previous quarter, MAIA stock was bought by institutional investors including:
  1. Geode Capital Management LLC
  2. Ritholtz Wealth Management
  3. Centric Wealth Management
In the last year, these company insiders have bought MAIA Biotechnology stock:
  1. Stan Smith (Director)
  2. Ngar Yee Louie (Director)
  3. Vlad Vitoc (CEO)
  4. Cristian Luput (Director)
  5. Steven M Chaouki (Director)
Learn More investors buying MAIA Biotechnology stock.